Off-Label Use of Atypical AntipsychoticsCause for Concern?

被引：0
作者：
Andrew McKean
Erik Monasterio
机构：
[1] The Princess Margaret Hospital,Pharmacy Department
[2] Hillmorton Hospital,Medlicott Academic Unit
来源：
CNS Drugs | 2012年 / 26卷
关键词：
Major Depressive Disorder; Anxiety Disorder; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Licensed indications for medicines were designed to regulate the claims that can be made about a medicine by a pharmaceutical company. Off-label prescribing (i.e. prescribing a drug for an indication outside of that for which it is licensed) is legal and an integral part of medical practice. In psychiatry, off-label prescribing is common and gives clinicians scope to treat patients who are refractory to standard therapy or where there is no licensed medication for an indication. However, efficacy or safety of such off-label use may not be established.
引用
收藏
页码：383 / 390
页数：7
相关论文
共 50 条
  • [31] Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: A retrospective series
    Ning, Anna Y.
    Theodoros, Theo
    Harris, Keith
    Isoardi, Katherine Z.
    AUSTRALASIAN PSYCHIATRY, 2023, 31 (02) : 195 - 200
  • [32] Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain
    Garcia-Carmona, Juan Antonio
    Simal-Aguado, Jorge
    Campos-Navarro, Maria Pilar
    Valdivia-Munoz, Francisco
    Galindo-Tovar, Alejandro
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (04) : 201 - 207
  • [33] Use of atypical antipsychotics for treatment-resistant major depressive disorder
    Papakostas G.I.
    Shelton R.C.
    Current Psychiatry Reports, 2008, 10 (6) : 481 - 486
  • [34] The use of atypical antipsychotics in traumatic brain injury
    Elovic, EP
    Lansang, R
    Li, YL
    Ricker, JH
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2003, 18 (02) : 177 - 195
  • [35] On- and off-label utilisation of antipsychotics in Australia (2000-2021): Retrospective analysis of two medication datasets
    Radha Krishnan, Ramya Padmavathy
    Harrison, Christopher
    Buckley, Nicholas
    Raubenheimer, Jacques Eugene
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2024, 58 (04) : 320 - 333
  • [36] Off-label use of second generation antipsychotics for post-traumatic stress disorder in the Department of Veterans Affairs: time trends and sociodemographic, comorbidity, and regional correlates
    Bauer, Mark S.
    Lee, Austin
    Li, Mingfei
    Bajor, Laura
    Rasmusson, Ann
    Kazis, Lewis E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (01) : 77 - 86
  • [37] The use of atypical Antipsychotics after traumatic brain injury
    Elovic, Elie Paul
    Jasey, Neil N., Jr.
    Eisenberg, Michal E.
    JOURNAL OF HEAD TRAUMA REHABILITATION, 2008, 23 (02) : 132 - 135
  • [38] Fatalities Associated with Therapeutic Use and Overdose of Atypical Antipsychotics
    Adam J. Trenton
    Glenn W. Currier
    Frank L. Zwemer
    CNS Drugs, 2003, 17 : 307 - 324
  • [39] Trends and off-label utilization of antipsychotics in children and adolescents from 2016 to 2021 in China: a real-world study
    Wang, Zhaojian
    Jiang, Meizhu
    Jun, Hong
    Guo, Shanshan
    Huo, Jiping
    Zhao, Zhigang
    Ying, Gong
    Cao, Li
    CHILD AND ADOLESCENT PSYCHIATRY AND MENTAL HEALTH, 2024, 18 (01)
  • [40] Effects of the anti-inflammatory pentoxifylline on psychiatric and neuropsychiatric conditions: exploring various off-label utilities with meta-analyses
    Ramzi, Ahmed
    Maya, Subhia
    Balousha, Nadeen
    Amin, Mufreh
    Powell, Robert Charles
    Shiha, Mostafa Ramzi
    INFLAMMOPHARMACOLOGY, 2025, 33 (01) : 105 - 119
12345